Allogene Therapeutics Reports First Quarter 2019 Financial Results

Go back to Allogene Therapeutics Reports First Quarter 2019 Financial Results
(NASDAQ: ALLO) Delayed: 2.08 --0 (-0%)
Previous Close $2.08    52 Week High
Open $2.08    52 Week Low
Day High $2.08    P/E N/A 
Day Low $2.08    EPS
Volume 35,908